COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 70 filers reported holding COGENT BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,337,500 | -6.9% | 650,000 | +13.0% | 2.08% | -7.3% |
| Q2 2023 | $6,808,000 | +14.7% | 575,000 | +4.5% | 2.25% | +28.1% |
| Q1 2023 | $5,935,000 | -35.8% | 550,000 | -31.2% | 1.75% | -55.6% |
| Q4 2022 | $9,248,000 | +3.3% | 800,000 | +33.3% | 3.95% | +57.1% |
| Q3 2022 | $8,952,000 | +10.3% | 600,000 | -33.3% | 2.51% | -40.6% |
| Q2 2022 | $8,118,000 | -36.2% | 900,000 | -47.1% | 4.23% | +53.0% |
| Q1 2022 | $12,733,000 | -12.7% | 1,700,000 | 0.0% | 2.76% | -47.1% |
| Q4 2021 | $14,586,000 | +15.6% | 1,700,000 | +13.3% | 5.23% | +41.7% |
| Q3 2021 | $12,615,000 | -2.8% | 1,500,000 | -6.2% | 3.69% | +3.4% |
| Q2 2021 | $12,976,000 | -7.6% | 1,600,000 | 0.0% | 3.57% | +8.0% |
| Q1 2021 | $14,048,000 | +13.7% | 1,600,000 | +45.5% | 3.30% | +19.9% |
| Q4 2020 | $12,353,000 | – | 1,100,000 | – | 2.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $12,643,000 | 5.20% |
| COMMODORE CAPITAL LP | 1,367,582 | $11,091,000 | 3.86% |
| Ghost Tree Capital, LLC | 1,600,000 | $12,976,000 | 3.57% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $13,159,000 | 3.27% |
| Atlas Venture Associates IX, LLC | 916,832 | $7,436,000 | 1.31% |
| VR Adviser, LLC | 1,088,817 | $8,830,000 | 1.07% |
| Logos Global Management LP | 1,420,500 | $11,520,000 | 0.97% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 198,245 | $1,608,000 | 0.72% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $2,658,000 | 0.68% |
| BVF INC/IL | 1,532,282 | $12,427,000 | 0.47% |